Skip to main content Accessibility help
×
Home
  • Print publication year: 2013
  • Online publication date: December 2013

Chapter 3 - Epidemiologicalconsiderations in neuropathic pain

from Section 1 - The Clinical Presentation of Neuropathic Pain

References

1. HelgasonS, PeturssonG, GudmundssonS, SigurdssonJA.Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. Br Med J 2000;321:794–6.
2. BouhassiraD, ChassanyO, GaillatJ, et al. Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice. Pain 2012;153:342–9.
3. Van AckerK, BouhassiraD, De BacquerD, et al. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes Metab 2009;35(3):206–13.
4. DaviesM, BrophyS, WilliamsR, TaylorA.The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 2006;29:1518–22.
5. DaousiC, MacFarlaneIA, WoodwardA, et al. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med 2004;21:976–82.
6. GärtnerR, JensenMB, NielsenJ, et al. Prevalence of and factors associated with persistent pain following breast cancer surgery. J Am Med Assoc 2009;302(18):1985–92.
7. GuastellaV, MickG, SorianoC, et al. A prospective study of neuropathic pain induced by thoracotomy: incidence, clinical description, and diagnosis. Pain 2011;152(1):74–81.
8. KehletH, JensenTS, WoolfCJ.Persistent postsurgical pain: risk factors and prevention. Lancet 2006;367:1618–25.
9. NikolajsenL, BrandsborgB.Postamputation pain. In CerveroF, JensenTS, Eds. Handbook of Clinical Neurology, Vol. 81: Pain. Amsterdam: Elsevier; 2006, pp. 679–86.
10. PoobalanAS, BruceJ, SmithWC, et al. A review of chronic pain after inguinal herniorrhaphy. Clin J Pain 2003;19:48–54.
11. MoulinDE, FoleyKM, EbersGC.Pain syndromes in multiple sclerosis. Neurology 1988;38(12):1830–4.
12. SolaroC, BrichettoG, AmatoMP, et al. PaIMS Study Group. The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study. Neurology 2004;63(5):919–21.
13. SvendsenKB, JensenTS, OvervadK, et al. Pain in patients with multiple sclerosis: a population-based study. Arch Neurol 2003;60:1089–94.
14. OsterbergA, BoivieJ, ThuomasKA.Central pain in multiple sclerosis – prevalence and clinical characteristics. Eur J Pain 2005;9:531–42.
15. BrochetB, DeloireMS, OualletJC, et al. Pain and quality of life in the early stages after multiple sclerosis diagnosis: a 2-year longitudinal study. Clin J Pain 2009;25:211–17.
16. SiddallPJ, McClellandJM, RutkowskiSB, CousinsMJ.A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury. Pain 2003;103:249–57.
17. SiddallPJ, TaylorDA, McClellandJM, RutkowskiSB, CousinsMJ.Pain report and the relationship of pain to physical factors in the first 6 months following spinal cord injury. Pain 1999;81:187–97.
18. AndersenG, VestergaardK, Ingeman-NielsenM, JensenTS.Incidence of central post-stroke pain. Pain 1995;61:187–93.
19. KlitH, FinnerupNB, AndersenG, JensenTS.Central poststroke pain: a population-based study. Pain 2011;152(4):818–24.
20. García de ParedesML, del Moral GonzálezF, Martínez del PradoP, et al. First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the ON study. Ann Oncol 2011;22(4):924–30.
21. KerbaM, WuJS, DuanQ, HagenNA, BennettMI.Neuropathic pain features in patients with bone metastases referred for palliative radiotherapy. J Clin Oncol 2010;28(33):4892–7.
22. BowsherD.Neurogenic pain syndromes and their management. Br Med Bull 1991;47:644–66.
23. DworkinRH, BackonjaM, RowbothamMC, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003;60:1524–34.
24. IrvingGA.Contemporary assessment and management of neuropathic pain. Neurology 2005;64(Suppl 3):S21–7.
25. BouhassiraD, AttalN.Diagnosis and assessment of neuropathic pain: the saga of clinical tools. Pain 2011;152(3 Suppl):S74–83.
26. BennettM.The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain 2001;92:147–57.
27. BennettMI, SmithBH, TorranceN, PotterJ.The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain 2005;6:149–58.
28. TorranceN, SmithBH, BennettMI, LeeAJ.The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain 2006;7:281–9.
29. BouhassiraD, Lantéri-MinetM, AttalN, LaurentB, TouboulC.Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 2008;136:380–7.
30. BouhassiraD, AttalN, AlchaarH, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005;114:29–36.
31. GustorffB, DornerT, LikarR, et al. Prevalence of self-reported neuropathic pain and impact on quality of life : a prospective representative survey. Acta Anaesthesiol Scand 2008;52:132–6.
32. TothC, LanderJ, WiebeS.The prevalence and impact of chronic pain with neuropathic pain symptoms in the general population. Pain Med 2009;10:918–29.
33. TreedeRD, JensenTS, CampbellJN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008;70:1630–5.
34. DaviesHTO, CrombieIK, MacraeWA, RogersKM.Pain clinic patients in northern Britain. The Pain Clinic 1992;5:129–35.
35. GrondS, ZechD, DiefenbachC, RadbruchL, LehmannKA.Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain 1996;64:107–14.
36. DielemanJP, KerklaanJ, HuygenFJ, BoumaPA, SturkenboomMC.Incidence rates and treatment of neuropathic pain conditions in the general population. Pain 2008;137:681–8.
37. DothAH, HanssonPT, JensenMP, TaylorRS.The burden of neuropathic pain: a systematic review and meta-analysis of health utilities. Pain 2010;149:338–44.
38. GálvezR, MarsalC, VidalJ, RuizM, RejasJ.Cross-sectional evaluation of patient functioning and health-related quality of life in patients with neuropathic pain under standard care conditions. Eur J Pain 2007;11:244–55.
39. GoreM, BrandenburgNA, HoffmanDL, TaiKS, StaceyB.Burden of illness in painful diabetic peripheral neuropathy: the patients’ perspectives. J Pain 2006;7:892–900.
40. GoreM, DukesE, RowbothamDJ, TaiKS, LeslieD.Clinical characteristics and pain management among patients with painful peripheral neuropathic disorders in general practice settings. Eur J Pain 2007;11:652–64.
41. JensenMP, ChodroffMJ, DworkinRH.The impact of neuropathic pain on health-related quality of life: review and implications. Neurology 2007;68:1178–82.
42. McDermottAM, ToelleTR, RowbothamDJ, SchaeferCP, DukesEM.The burden of neuropathic pain: results from a cross-sectional survey. Eur J Pain 2006;10:127–35.
43. Meyer-RosbergK, KvarnströmA, KinnmanE, et al. Peripheral neuropathic pain – a multidimensional burden for patients. Eur J Pain 2001;5:379–89.
44. SmithBH, TorranceN, BennettMI, LeeAJ.Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community. Clin J Pain 2007;23:143–9.
45. AttalN, Lanteri-MinetM, LaurentB, FermanianJ, BouhassiraD.The specific disease burden of neuropathic pain: results of a French nationwide survey. Pain 2011;152:2836–43.
46. TorranceN, SmithBH, WatsonMC, BennettMI.Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin. Fam Pract 2007;24:481–5.